Cargando…
Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling
Prostate cancer is the most common cancer among men worldwide. However, current treatments for prostate cancer patients in advanced stage often fail because of relapse. Prostate cancer stem cells (PCSCs) are resistant to most standard therapies, and are considered to be a major mechanism of cancer m...
Autores principales: | Qin, Wei, Zheng, Yongjiang, Qian, Bin-Zhi, Zhao, Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368180/ https://www.ncbi.nlm.nih.gov/pubmed/28400729 http://dx.doi.org/10.3389/fphar.2017.00153 |
Ejemplares similares
-
Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells
por: Wang, Jinheng, et al.
Publicado: (2017) -
Potential Applications of Nanotechnology in Urological Cancer
por: He, Ming-Hui, et al.
Publicado: (2018) -
Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway
por: Bu, Tong, et al.
Publicado: (2023) -
Cancer Chemoprevention Using Nanotechnology-Based Approaches
por: Desai, Preshita, et al.
Publicado: (2020) -
Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
por: Qian, Chen, et al.
Publicado: (2020)